GENEVA, July 31 -- GEMMA BIOTHERAPEUTICS, INC. filed a patent application (US2026/012389) for “COMPOSITIONS AND METHODS FOR TREATING DYSTROPHIN MEDIATED DISEASES”. With publication no. WO/2026/161721, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/47
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....